Andrew Chang

Professor Andrew Chang AM

MBBS (Hons), PhD FRANZCO, FRACS

Background

Andrew Chang is a vitreoretinal surgeon and ophthalmologist. He holds academic appointments of Conjoint Professor Department of Surgery UNSW and Clinical Associate Professor at The University of Sydney. He is a consultant ophthalmologist and the Head of Ophthalmology at the Sydney Eye Hospital. He is the Medical Director of Sydney Retina Clinic. Professor Chang graduated from the University of Sydney Medical School and trained at the Sydney Eye Hospital with fellowships at Royal Victorian Eye and Ear Hospital and in the USA. He was awarded a PhD for retinal research conducted in the Universities of California and Sydney

Associate Professor Andrew Chang

In Australia, he is clinician advisor to the Department of Health Australia and to the TGA on new technologies in Ophthalmology. 

He serves as Chair of the Board of the
Sydney Eye Hospital Foundation. His commitment to international Ophthalmology includes the role of Secretary General of the Asia-Pacific Vitreoretinal Society (APVRS) and deputy Secretary-General of the Asia-Pacific Academy of Ophthalmology (APAO). 

 

 

Professor Chang’s professional awards include the 2022 Tano Lecture of the APVRS, Achievement Award, Distinguished Service Award, and the Outstanding Service in Prevention of Blindness Award of the Asia- Pacific Academy of Ophthalmology (APOA) and RANZCO Excellence in Teaching Award. 

In 2023 his contributions to ophthalmology and retinal surgery were acknowledged in his being awarded as a Member of the Order of Australia (AM).

Related Publications

Scientific Journal Publications

Spooner KL, Fraser-Bell S, Hong T, Wong JG, Chang AA. Long-term outcomes of anti-VEGF treatment of retinal vein occlusion. Eye (Lond). 2021 Jun 11.

Read more
Scientific Journal Publications

Ogura Y, Jaffe GJ, Cheung CM, Kokame GT, Iida T, Takahashi K, Lee WK, Chang AA, Monés J, D’Souza D, Weissgerber G. Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK. British Journal of Ophthalmology. 2021 Jul 21.

Read more
Scientific Journal Publications

Jhaveri, C., Wykoff, C.C., Khanani, A.M., Eandi, C.M., Chang, A., Guruprasad, B., Gedif, K.A. and Singer, M., 2021. Early Residual Fluid-free Status and Long-term BCVA outcomes: A Treatment Agnostic, Post-hoc Analysis of Pooled HAWK and HARRIER Data. American Journal of Ophthalmology.

Read more
Scientific Journal Publications

Racic T, Chang A, Fernando N, Brandli A, Natoli R, Penfold P, Provis JM, Rutar M. Anti-inflammatory and neuroprotective properties of the corticosteroid fludrocortisone in retinal degeneration. Exp Eye Res. 2021 Sep 9:108765. doi: 10.1016/j.exer.2021.108765. Epub ahead of print. PMID: 34509498.

Read more

Our Affiliates